BFC Planning’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36K Hold
1,373
– – ﹤0.01% 2840
2026
Q2
$6.16K Hold
1,373
– – ﹤0.01% 2596
2026
Q1
$5.07K Hold
1,373
– – ﹤0.01% 2304
2025
Q4
$4.81K Hold
1,373
– – ﹤0.01% 2374
2025
Q3
$2.94K Hold
1,373
– – ﹤0.01% 2363
2025
Q2
$3.09K Hold
1,373
– – ﹤0.01% 2205
2025
Q1
$1.88K Hold
1,373
– – ﹤0.01% 2318
2024
Q4
$2.17K Hold
1,373
– – ﹤0.01% 2269
2024
Q3
$1.7K Buy
+1,373
New +$1.73K ﹤0.01% 2310

Other funds holding APYX

BFC Planning's APYX Position: Q3 2026 in Review

BFC Planning held its Apyx Medical (APYX) position steady in Q3 2026 at 1,373 shares worth $3.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

BFC Planning first reported a position in APYX in Q3 2024 and has held it in 9 quarters since. The position peaked at $6.16K in Q2 2026. 55 funds tracked by Wall St. Rank hold APYX as of Q3 2026.

  • BFC Planning held 1,373 shares of Apyx Medical worth $3.36K as of Q3 2026.
  • BFC Planning left its Apyx Medical share count unchanged in Q3 2026.
  • Apyx Medical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2840 holding.
  • BFC Planning first reported a position in Apyx Medical in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Apyx Medical position peaked at $6.16K in Q2 2026.
  • 55 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.